Erratum to Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA

• Kenan Zhang,
• Xing Liu,
• Guanzhang Li,
• Xin Chang,
• Shouwei Li,
• Jing Chen,
• Zheng Zhao,
• Jiguang Wang,
• Tao Jiang,
• Ruichao Chai

Affiliations

Kenan Zhang

Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Xing Liu

Department of Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Guanzhang Li

Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Xin Chang

Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China

Shouwei Li

Department of Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing 100093, China

Jing Chen

Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Zheng Zhao

Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Jiguang Wang

Division of Life Science and State Key Laboratory of Molecular Neuroscience, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong SAR 999077, China

Tao Jiang

Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China

Ruichao Chai

Department of Molecular Pathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China